FindTrial
Sign In

Role of Virechana karma (Purgation therapy )and Khanda Pippaliavaleha (Ayurvedic formulation ) in the treatment of acidity

A comparative clinical study to evaluate the efficacy of Virechana karma and Khanda Pippaliavaleha in the management of Amlapitta

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012546
Enrollment
40
Registered
2018-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K290- Acute gastritis Health Condition 2: null- Amlapitta( hyperacidity)

Interventions

Intervention1: Virechana karma: 1 Sitting of virechana karma followed by placebo for 45 days with water Control Intervention1: Khand pippali Awaleha: Khand Pippali avaleha 5 g BD for 2 months and foll

Sponsors

Rishikul campus Haridwar
Lead Sponsor
Sanjay Tripathi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Amlapitta defined as those patients with burning sensation in epigastric region(hritkanthadaha),loss of appetite(aruchi),nausea(utklesh ),acid reflux( tiktamlodgar) , flatulence( adhman),constipation ( vibandha),bhrama (reeling oh head),fatigue(klama),indigestion (avipaka),vomiting (chardi)

Exclusion criteria

Exclusion criteria: age below 20 yr and more than 60 yr, known case of Gastric and Duodenal ulcer , known case of gastritic carcinoma Chronic gastritis( more than 1 yr)

Design outcomes

Primary

MeasureTime frame
Wilcoxon signed rank test Independent sample t test Man-Whitney testTimepoint: Outcome will be asssesed after 60 days.—

Secondary

MeasureTime frame
not yet completedTimepoint: Not yet completed—

Countries

India

Contacts

Public ContactAnshul

Rishikul campus ,Uttarakhand Ayurved University

dr.anshul17@gmail.com9416470813

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026